Abstract
Restarting of antiplatelet therapy (AT) for patients with a history of intracerebral hemorrhage (ICH) is still a clinical dilemma in China. We aimed t......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
